Thursday, October 8, 2026 SourcesAbout🌓
🇨🇦 CA ▾
Américas🇧🇷 Brasil🇺🇸 United States🇨🇦 Canada🇻🇪 Venezuela🇲🇽 México🇦🇷 Argentina
Europa🇫🇷 France🇬🇧 United Kingdom🇪🇸 España🇵🇹 Portugal🇩🇪 Deutschland🇷🇺 Россия
Ásia-Pacífico🇯🇵 日本🇦🇺 Australia🇮🇳 India🇰🇷 대한민국🇨🇳 中国
África🇿🇦 South Africa
BREAKING
› Panthers’ Brad Marchand out week-to-week with leg injury› Def Leppard, Goo Goo Dolls play Toronto March 9, one of 5 Canadian cities on 2027 tour› North York men charged with multiple offences in Milton robbery probe› Audit committee hears update on snow-clearing program's effectiveness, recommendations for improvement› If burgers were votes, Lorne Doerkson might be your new B.C. premier› Disney pitches Paramount, Universal on Imax’s big-screen rival› A’ja Wilson named WNBA MVP for record-breaking third year in a row› Should Yankees’ Boone be on his way out after team’s swift playoff exit?› Michael Taube: With Alexander out of the Toronto mayoral race, Brad Bradford is in the driver’s seat› Halifax high school lockdown lifted as police investigate weapons threat› Panthers’ Brad Marchand out week-to-week with leg injury› Def Leppard, Goo Goo Dolls play Toronto March 9, one of 5 Canadian cities on 2027 tour› North York men charged with multiple offences in Milton robbery probe› Audit committee hears update on snow-clearing program's effectiveness, recommendations for improvement› If burgers were votes, Lorne Doerkson might be your new B.C. premier› Disney pitches Paramount, Universal on Imax’s big-screen rival› A’ja Wilson named WNBA MVP for record-breaking third year in a row› Should Yankees’ Boone be on his way out after team’s swift playoff exit?› Michael Taube: With Alexander out of the Toronto mayoral race, Brad Bradford is in the driver’s seat› Halifax high school lockdown lifted as police investigate weapons threat
Business

Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting

Financial Post ·

SOUTH SAN FRANCISCO, Calif. -- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that data from Study 250-902 (NCT03227042), a prospective, multicenter, multinational, noninterventional, longitudinal natural history study designed to characterize disease progression in pediatric participants with severe, non-attenuated Sanfilippo Syndrome Type B (MPS IIIB) will be presented at the 55 th Child Neurology Society (CNS) Annual Meeting , taking place October 14–17, 2026, in Montréal, Québec, Canada.

The poster will be available on the Spruce Biosciences website following the presentation.

Read More

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

See all ›

Disney pitches Paramount, Universal on Imax’s big-screen rival

Financial Post · 16 min ago

Stephen A. Jarislowsky, admired Canadian fund manager, dies at 101

Financial Post · 36 min ago

YYForce Expands 24iFM With Services Marketplace and Lifestyle Advertising

Financial Post · 47 min ago

Sienna Continues Platform Growth in Ontario

Financial Post · 51 min ago

More in Business

See all ›

Disney pitches Paramount, Universal on Imax’s big-screen rival

Financial Post · 16 min ago

Stephen A. Jarislowsky, admired Canadian fund manager, dies at 101

Financial Post · 36 min ago

YYForce Expands 24iFM With Services Marketplace and Lifestyle Advertising

Financial Post · 47 min ago

Sienna Continues Platform Growth in Ontario

Financial Post · 51 min ago

Altus Group to Release Q3 2026 Financial Results on November 5

Financial Post · 52 min ago

AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting

Financial Post · 53 min ago